These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15778582)

  • 1. The application of dose-rate volume histograms and survival fractions to multicellular dosimetry.
    Malaroda A; Flux G; Ott R
    Cancer Biother Radiopharm; 2005 Feb; 20(1):58-65. PubMed ID: 15778582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECT.
    Pacilio M; Amato E; Lanconelli N; Basile C; Torres LA; Botta F; Ferrari M; Diaz NC; Perez MC; Fernández M; Lassmann M; Gil AV; Cremonesi M
    Phys Med Biol; 2015 Mar; 60(5):1945-64. PubMed ID: 25668639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Monte Carlo-based 90Y SPECT reconstruction.
    Elschot M; Lam MG; van den Bosch MA; Viergever MA; de Jong HW
    J Nucl Med; 2013 Sep; 54(9):1557-63. PubMed ID: 23907758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of BED and EUD concepts in heterogeneous radioactivity distributions on a multicellular scale for targeted radionuclide therapy.
    Kalogianni E; Flux GD; Malaroda A
    Cancer Biother Radiopharm; 2007 Feb; 22(1):143-50. PubMed ID: 17627423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.
    Konijnenberg M; Melis M; Valkema R; Krenning E; de Jong M
    J Nucl Med; 2007 Jan; 48(1):134-42. PubMed ID: 17204710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A voxel-dose algorithm of heterogeneous activity distribution for Monte-Carlo simulation of radionuclide therapy dosimetry.
    Lin H; Jing J; Cai J; Xu L
    Cancer Biother Radiopharm; 2012 Aug; 27(6):344-52. PubMed ID: 22804457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
    Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
    J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular dosimetry in voxel geometry for targeted radionuclide therapy.
    Malaroda A; Flux GD; Buffa FM; Ott RJ
    Cancer Biother Radiopharm; 2003 Jun; 18(3):451-61. PubMed ID: 12954133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
    Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
    J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy.
    Autret D; Bitar A; Ferrer L; Lisbona A; Bardiès M
    Cancer Biother Radiopharm; 2005 Feb; 20(1):77-84. PubMed ID: 15778585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals.
    Amato E; Leotta S; Italiano A; Baldari S
    Phys Med; 2015 Jul; 31(5):536-41. PubMed ID: 25979209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation.
    Grudzinski JJ; Yoriyaz H; Deluca PM; Weichert JP
    Appl Radiat Isot; 2010 Jan; 68(1):59-65. PubMed ID: 19879154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioembolization with (90)Y-labeled microspheres: post-therapeutic therapy validation with Bremsstrahlung-SPECT].
    Grober OS; Nultsch M; Laatz K; Ulrich G; Seidensticker R; Pethe A; Dudeck O; Pech M; Knoop BO; Ricke J; Amthauer H; Geworski L
    Z Med Phys; 2011 Dec; 21(4):274-80. PubMed ID: 21719264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
    Walrand S; Flux GD; Konijnenberg MW; Valkema R; Krenning EP; Lhommel R; Pauwels S; Jamar F
    Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S57-68. PubMed ID: 21484382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison of 90Y, 32P, and 186Re radiocolloids in craniopharyngioma treatments.
    Sadeghi M; Karimi E; Hosseini SH
    Med Phys; 2009 Nov; 36(11):5022-6. PubMed ID: 19994512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.